Impact of a probiotic chewable tablet on stool habits and microbial profile in children with functional constipation: A randomized controlled clinical trial
Constipation is a common and typically multifactorial childhood complaint, and the clinical management of childhood functional constipation (FC) is challenging. A randomized, single-blind, placebo-controlled, multi-center clinical trial was conducted in 92 children (47 from Beijing, China and 45 fro...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-08-01
|
| Series: | Frontiers in Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2022.985308/full |
| _version_ | 1817999066749992960 |
|---|---|
| author | Dan Gan Jialun Chen Xin Tang Luyao Xiao Christopher J. Martoni Gregory Leyer Guixia Huang Wei Li |
| author_facet | Dan Gan Jialun Chen Xin Tang Luyao Xiao Christopher J. Martoni Gregory Leyer Guixia Huang Wei Li |
| author_sort | Dan Gan |
| collection | DOAJ |
| description | Constipation is a common and typically multifactorial childhood complaint, and the clinical management of childhood functional constipation (FC) is challenging. A randomized, single-blind, placebo-controlled, multi-center clinical trial was conducted in 92 children (47 from Beijing, China and 45 from Shanghai, China) aged 4–12 with FC according to Rome III criteria. Children were assigned to receive a probiotic chewable tablet (5 × 109 CFU/day, n = 47), consisting of Lactobacillus acidophilus DDS-1® and Bifidobacterium animalis subsp. lactis UABla-12™ or placebo (n = 45), twice daily for 4 weeks, followed by a week follow-up period. Results suggested that the probiotic group showed a faster and more pronounced normalization of stool frequency over the intervention period (3.15 vs. 1.83) when compared to placebo group (2.51 vs. 1.87). Meanwhile, the percentage of subjects with hard defecation decreased from 43 to 14% in the probiotic group, while the percentage of subjects with normal defecation increased from 56 to 80% in the probiotic group, further confirming the normalization of stools habits. This randomized controlled trial demonstrated the potential of a probiotic chewable tablet containing L. acidophilus DDS-1® and B. Lactis UABla-12™ as a daily probiotic dosage form for children with FC. |
| first_indexed | 2024-04-14T03:03:02Z |
| format | Article |
| id | doaj.art-b30dc3b4c9a04cf78c2b693a72ffa788 |
| institution | Directory Open Access Journal |
| issn | 1664-302X |
| language | English |
| last_indexed | 2024-04-14T03:03:02Z |
| publishDate | 2022-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Microbiology |
| spelling | doaj.art-b30dc3b4c9a04cf78c2b693a72ffa7882022-12-22T02:15:52ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2022-08-011310.3389/fmicb.2022.985308985308Impact of a probiotic chewable tablet on stool habits and microbial profile in children with functional constipation: A randomized controlled clinical trialDan Gan0Jialun Chen1Xin Tang2Luyao Xiao3Christopher J. Martoni4Gregory Leyer5Guixia Huang6Wei Li7Sirio Pharma Co., Ltd., Shantou, ChinaSirio Pharma Co., Ltd., Shantou, ChinaSirio Pharma Co., Ltd., Shantou, ChinaCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing, ChinaChr. Hansen, Windsor, WI, United StatesChr. Hansen, Windsor, WI, United StatesSirio Pharma Co., Ltd., Shantou, ChinaCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing, ChinaConstipation is a common and typically multifactorial childhood complaint, and the clinical management of childhood functional constipation (FC) is challenging. A randomized, single-blind, placebo-controlled, multi-center clinical trial was conducted in 92 children (47 from Beijing, China and 45 from Shanghai, China) aged 4–12 with FC according to Rome III criteria. Children were assigned to receive a probiotic chewable tablet (5 × 109 CFU/day, n = 47), consisting of Lactobacillus acidophilus DDS-1® and Bifidobacterium animalis subsp. lactis UABla-12™ or placebo (n = 45), twice daily for 4 weeks, followed by a week follow-up period. Results suggested that the probiotic group showed a faster and more pronounced normalization of stool frequency over the intervention period (3.15 vs. 1.83) when compared to placebo group (2.51 vs. 1.87). Meanwhile, the percentage of subjects with hard defecation decreased from 43 to 14% in the probiotic group, while the percentage of subjects with normal defecation increased from 56 to 80% in the probiotic group, further confirming the normalization of stools habits. This randomized controlled trial demonstrated the potential of a probiotic chewable tablet containing L. acidophilus DDS-1® and B. Lactis UABla-12™ as a daily probiotic dosage form for children with FC.https://www.frontiersin.org/articles/10.3389/fmicb.2022.985308/fullfunctional constipationmicrobiomeprobiotic chewablechildrenclinical trial |
| spellingShingle | Dan Gan Jialun Chen Xin Tang Luyao Xiao Christopher J. Martoni Gregory Leyer Guixia Huang Wei Li Impact of a probiotic chewable tablet on stool habits and microbial profile in children with functional constipation: A randomized controlled clinical trial Frontiers in Microbiology functional constipation microbiome probiotic chewable children clinical trial |
| title | Impact of a probiotic chewable tablet on stool habits and microbial profile in children with functional constipation: A randomized controlled clinical trial |
| title_full | Impact of a probiotic chewable tablet on stool habits and microbial profile in children with functional constipation: A randomized controlled clinical trial |
| title_fullStr | Impact of a probiotic chewable tablet on stool habits and microbial profile in children with functional constipation: A randomized controlled clinical trial |
| title_full_unstemmed | Impact of a probiotic chewable tablet on stool habits and microbial profile in children with functional constipation: A randomized controlled clinical trial |
| title_short | Impact of a probiotic chewable tablet on stool habits and microbial profile in children with functional constipation: A randomized controlled clinical trial |
| title_sort | impact of a probiotic chewable tablet on stool habits and microbial profile in children with functional constipation a randomized controlled clinical trial |
| topic | functional constipation microbiome probiotic chewable children clinical trial |
| url | https://www.frontiersin.org/articles/10.3389/fmicb.2022.985308/full |
| work_keys_str_mv | AT dangan impactofaprobioticchewabletabletonstoolhabitsandmicrobialprofileinchildrenwithfunctionalconstipationarandomizedcontrolledclinicaltrial AT jialunchen impactofaprobioticchewabletabletonstoolhabitsandmicrobialprofileinchildrenwithfunctionalconstipationarandomizedcontrolledclinicaltrial AT xintang impactofaprobioticchewabletabletonstoolhabitsandmicrobialprofileinchildrenwithfunctionalconstipationarandomizedcontrolledclinicaltrial AT luyaoxiao impactofaprobioticchewabletabletonstoolhabitsandmicrobialprofileinchildrenwithfunctionalconstipationarandomizedcontrolledclinicaltrial AT christopherjmartoni impactofaprobioticchewabletabletonstoolhabitsandmicrobialprofileinchildrenwithfunctionalconstipationarandomizedcontrolledclinicaltrial AT gregoryleyer impactofaprobioticchewabletabletonstoolhabitsandmicrobialprofileinchildrenwithfunctionalconstipationarandomizedcontrolledclinicaltrial AT guixiahuang impactofaprobioticchewabletabletonstoolhabitsandmicrobialprofileinchildrenwithfunctionalconstipationarandomizedcontrolledclinicaltrial AT weili impactofaprobioticchewabletabletonstoolhabitsandmicrobialprofileinchildrenwithfunctionalconstipationarandomizedcontrolledclinicaltrial |